Company: CERO
Filing Date: 2025-05-02
Form Type: PRER14A
Source: 0001213900-25-039149
Chunk: 94

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-05-02
Form: PRER14A
Chunk 94
---
 “Certificates of Designations”) in their entirety for a complete description of the rights and preferences of the Company’s securities. General We are authorized to issue up to 1,000,000,000 shares of Common Stock, $0.0001 par value per share (“Common Stock”), and 10,000,000 shares of preferred stock, par value $0.0001 per share (the “Preferred Stock”). As of the date of this proxy statement, the Company currently has outstanding (i) 1,429shares of Series A Preferred Stock with a conversion value of approximately $1.4million, convertible into shares of Common Stock at a conversion rate of the stated value thereof divided by a current effective conversion price of $1.96; (ii) 198shares of Series B Preferred Stock with a conversion value of approximately $0.2million, convertible into shares of Common Stock at a conversion rate of the stated value thereof divided by a floating conversion price of 80% of the lowest volume weighted average price during the five trading days immediately prior to conversion; (iii) 2,537shares of Series C Preferred Stock with a stated value of approximately $2.5million, convertible into shares of Common Stock at a conversion rate of the stated value thereof divided by a conversion price of $1.96 (iv) Series A Warrants to purchase 6,127shares of Common Stock at an exercise price of $139.00 per share; (v) Series C Warrants to purchase 81,753shares of Common Stock at an exercise price of $0.04; (vi) December 2024 and January 2025 Common Warrants to purchase an aggregate of 247,914shares of Common Stock at an exercise price ranging from $5.61 to $5.82, (vii) February 2025 Common Warrants to purchase an aggregate of 2,551,020shares of Common Stock at an exercise price of $1.96, (viii) Pre -FundedWarrants to purchase an aggregate of 215,740shares of Common Stock at an exercise price of $0.0001, and (ix) Public Warrants and Private Placement Warrants to purchase an aggregate of 91,925shares of Common Stock at an exercise price of $1,150.00 per share. Preferred Stock The Board is authorized to issue “blank check” Preferred Stock, which may be issued in one or more series upon the authorization of the Board. The Board is authorized to